|
Noven Pharmaceuticals makes it easier to get drugs beneath the surface. The company develops drugs using its transdermal drug delivery system, which administers medication through a patch attached to the skin. Noven's patches include such female hormone replacement therapy products as Vivelle-Dot and CombiPatch, ADHD drug Daytrana (marketed by Shire), and a transmucosal lidocaine patch used for dental procedures. The company also produces and markets three psychiatric drugs. In 2009 Noven was acquired by Japanese drug-maker Hisamitsu Pharmaceutical for some $430 million.
|
| | | Contact Information | |
Address: |
11960 SW 144th St.
Miami, FL 33186
| | Phone: | 305-253-5099 | | Fax: | 305-251-1887 |
|
| Financial
Highlights | | Fiscal Year End: | December | | Revenue (2008): | 108.20 M | | Revenue Growth (1 yr): | 30.10% | | Employees (2008): | 610 | | Employee Growth (1 yr): | 4.10% |
|
|
Key People
| | • |
Chairman:
Wayne P. Yetter
| | • |
President and CEO:
Jeffrey F. Eisenberg
| | • |
VP and CFO:
Michael D. Price
|
|
|
